<DOC>
	<DOCNO>NCT00125385</DOCNO>
	<brief_summary>This study design investigate whether GC1008 , antibody neutralizes TGFb , safe treat patient idiopathic pulmonary fibrosis . The high dose without excessive side effect identify . Tests determine long GC1008 body excrete .</brief_summary>
	<brief_title>Study GC1008 Patients With Idiopathic Pulmonary Fibrosis ( IPF )</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Pulmonary Fibrosis</mesh_term>
	<mesh_term>Idiopathic Pulmonary Fibrosis</mesh_term>
	<mesh_term>Idiopathic Interstitial Pneumonias</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<criteria>Willing able provide write informed consent prior studyrelated procedure . Patients establish diagnosis IPF . Pulmonary Function Tests ( PFTs ) : FVC ≥ 50 % DLCO ≥ 25 % normal predict value . Able walk least 500 foot ( 150 meter ) 6minute Walk Test ( 6MWT ) . During 6MWT patient must require great 51/min supplemental oxygen maintain oxygen saturation &gt; 80 % Women pregnant lactating ; plan become pregnant within 9 month infusion . Women childbearing potential men consider father child unless take medically acceptable contraceptive precaution ; History clinically significant environmental exposure , include dust , mold , asbestos , pigeon bird may result interstitial lung disease , ingestion drug know cause pulmonary fibrosis bleomycin . History clinically significant respiratory disease IPF . History clinically significant cardiac , hepatic , renal disease . History cancer , precancerous state ( e.g . familial polyposis , BRCA1 , BRCA2 ) , nonmelanomatous skin cancer , within 5 year prior Screening . Use investigational drug administer part clinical trial within 12 week Screening . Other pathology might interfere assessment safety efficacy test article . Other clinically significant , uncontrolled medical condition , Investigator 's opinion , might interfere assessment followup .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>IPF</keyword>
	<keyword>Idiopathic</keyword>
	<keyword>Pulmonary</keyword>
	<keyword>Fibrosis</keyword>
</DOC>